
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
[ Fri, Apr 01st 2022 ]: WOPRAI
Josh Beck Maintained (BLND) at Buy with Decreased Target to $6 on, Apr 1st, 2022


🞛 This publication is a summary or evaluation of another publication
Josh Beck of Keybanc, Maintained "Blend Labs, Inc." (BLND) at Buy with Decreased Target from $10 to $6 on, Apr 1st, 2022.
Josh has made no other calls on BLND in the last 4 months.
There are 2 other peers that have a rating on BLND. Out of the 2 peers that are also analyzing BLND, 1 agrees with Josh's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Ryan Tomasello of "Keefe, Bruyette & Woods" Initiated at Hold and Held Target at $12 on, Monday, February 14th, 2022
This is the rating of the analyst that currently disagrees with Josh
- Michael Ng of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $9 on, Thursday, March 31st, 2022